Close Menu

NEW YORK – Bionano Genomics has again fallen out of compliance with Nasdaq listing requirements.

According to an April 24 filing with the US Securities and Exchange Commission, the genome mapping firm received a letter from Nasdaq on April 22, stating that for 30 consecutive days, its share price had closed below the $1.00 minimum required for continued listing.

At the close of the market on April 24, shares of Bionano traded at $.35.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.